scholarly article | Q13442814 |
P50 | author | Dirk Van Roost | Q123200032 |
Ine Dauwe | Q123200041 | ||
Lies Mollet | Q123200049 | ||
Leen De Taeye | Q123200067 | ||
Tom Verguts | Q45896549 | ||
Pieter van Mierlo | Q47985201 | ||
Veerle De Herdt | Q49072263 | ||
Paul Boon | Q87110922 | ||
Kristl Vonck | Q87110930 | ||
Robrecht Raedt | Q87110933 | ||
Stefanie Gadeyne | Q87634636 | ||
Evelien Carrette | Q90637962 | ||
Alfred Meurs | Q123200007 | ||
P2093 | author name string | Marlies van Bochove | |
P2860 | cites work | Updating P300: an integrative theory of P3a and P3b | Q24645237 |
Orienting and reorienting: the locus coeruleus mediates cognition through arousal | Q28276475 | ||
An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance | Q29615396 | ||
The effects of peripheral vagal nerve stimulation at a memory-modulating intensity on norepinephrine output in the basolateral amygdala | Q30312117 | ||
Vagus nerve stimulation for partial seizures. | Q32064483 | ||
Effect of vagal nerve stimulation on auditory and visual event-related potentials | Q33182414 | ||
Cancellation of EEG and MEG signals generated by extended and distributed sources | Q33554917 | ||
Enhanced recognition memory following vagus nerve stimulation in human subjects | Q33858053 | ||
Vagus nerve stimulation for refractory epilepsy. | Q34432642 | ||
Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic review | Q34589824 | ||
Vagus-nerve stimulation for the treatment of epilepsy | Q35172370 | ||
Common pathogenic mechanisms between depression and epilepsy: an experimental perspective | Q35573294 | ||
Response activation impairments in schizophrenia: evidence from the lateralized readiness potential | Q35618956 | ||
Decision making, the P3, and the locus coeruleus-norepinephrine system | Q36214791 | ||
Clinical experience with vagus nerve stimulation and deep brain stimulation in epilepsy | Q36906874 | ||
The locus coeruleus and noradrenergic modulation of cognition | Q37384698 | ||
Event-related potentials in clinical research: guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400. | Q37606808 | ||
The anatomical and functional relationship between the P3 and autonomic components of the orienting response | Q37765930 | ||
A roadmap for the development and validation of event-related potential biomarkers in schizophrenia research | Q37812747 | ||
Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response | Q37818749 | ||
Depression and epilepsy: A bidirectional relation? | Q37826767 | ||
The role of locus coeruleus in the antiepileptic activity induced by vagus nerve stimulation | Q37871070 | ||
Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. | Q37916564 | ||
Effects of locus coeruleus lesions on auditory, long-latency, event-related potentials in monkey. | Q41275415 | ||
Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat | Q41782749 | ||
Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission | Q42495232 | ||
Vagus nerve stimulation for refractory epilepsy: a Belgian multicenter study | Q42616023 | ||
Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study | Q42688507 | ||
Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation | Q44233180 | ||
Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures | Q46272251 | ||
Pupillometry and P3 index the locus coeruleus-noradrenergic arousal function in humans | Q46540087 | ||
Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain. | Q46962887 | ||
Efferent projections of the nucleus of the solitary tract to peri-locus coeruleus dendrites in rat brain: evidence for a monosynaptic pathway | Q48140596 | ||
Electrophysiologic studies of cervical vagus nerve stimulation in humans: II. Evoked potentials | Q48411646 | ||
Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes | Q48766109 | ||
Auditory event-related potentials (P300) in epileptic patients | Q48825150 | ||
Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat. | Q48922181 | ||
Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model | Q49072157 | ||
Long-term results of vagus nerve stimulation in refractory epilepsy | Q49169890 | ||
Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial. | Q50581052 | ||
Vagus nerve stimulation is associated with mood improvements in epilepsy patients. | Q51073580 | ||
Long-term effects of 24-month treatment with vagus nerve stimulation on behaviour in children with Lennox-Gastaut syndrome. | Q51950285 | ||
The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. | Q52021212 | ||
Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults | Q52052129 | ||
P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder. | Q52929200 | ||
The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes | Q55921579 | ||
The effect of the skull on event-related P300 | Q57411418 | ||
A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group | Q72541815 | ||
A Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve Stimulation | Q73057238 | ||
Guidelines for using human event-related potentials to study cognition: recording standards and publication criteria | Q73581007 | ||
Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial | Q74800943 | ||
Vagus nerve stimulation for refractory epilepsy in children: More to VNS than seizure frequency reduction | Q83241819 | ||
P433 | issue | 3 | |
P921 | main subject | biomarker | Q864574 |
P304 | page(s) | 612-622 | |
P577 | publication date | 2014-07-01 | |
P1433 | published in | Neurotherapeutics | Q15716631 |
P1476 | title | The P3 event-related potential is a biomarker for the efficacy of vagus nerve stimulation in patients with epilepsy | |
P478 | volume | 11 |
Q53076902 | Application of the P300 Event-Related Potential in the Diagnosis of Epilepsy Disorder: A Review. |
Q30404737 | Beta receptor-mediated modulation of the oddball P3 but not error-related ERP components in humans |
Q36177113 | Catecholaminergic Regulation of Learning Rate in a Dynamic Environment |
Q38759738 | Clinical Vagus Nerve Stimulation Paradigms Induce Pronounced Brain and Body Hypothermia in Rats |
Q92510251 | Current Directions in the Auricular Vagus Nerve Stimulation II - An Engineering Perspective |
Q48485966 | EEG Derived Brain Activity Reflects Treatment Response from Vagus Nerve Stimulation in Patients with Epilepsy |
Q48041066 | Epilepsy: closing the loop for patients with epilepsy |
Q58097939 | Invasive Neuromodulation for the Treatment of Pediatric Epilepsy |
Q40559096 | Noradrenergic and cholinergic modulation of late ERP responses to deviant stimuli |
Q47687069 | Open your eyes for prediction errors. |
Q48478224 | The effect of vagus nerve stimulation on response inhibition |
Q38585905 | Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part III. |
Q57170309 | Vagus nerve stimulation as a tool for enhancing extinction in exposure-based therapies |
Search more.